|
|
|
|
Developing new delivery routes for biological therapies is essential for creating more patient-centric and effective treatments. By using nanoforming techniques, it's possible to simplify dosing regimens and enhance patient comfort and compliance.
|
|
|
|
|
Review the challenges and intricacies of effectively delivering drugs to the lung and the value of using gentle particle processing techniques to enable delivery of sensitive drugs. Ultrafine particles enhance drug dispersion, minimize clearance, and boost therapeutic potential.
|
|
|
|
|
The ability to administer high doses of biologics subcutaneously offers advantages, including reduced treatment burden, improved patient convenience, and increased adherence. Explore a case study on how a new approach was used to develop a highly concentrated formulation.
|
|
|
|
|
Nanoform's CEO, Prof. Edward Hæggström, and Shawn Davies, Head of Drug Delivery, Biopharmaceuticals Development, AstraZeneca – a long-term partner of Nanoform – discuss the potential of nanoscale medicines and delivery devices to benefit patients.
|
|
|
|
|
|
|
Sergie Letser, Deputy CCO, presents an overview of Nanoform’s novel large molecule nanoforming technology capabilities and current capacity. Nanoform's approach allows for the development of alternative delivery routes that wouldn’t be possible with traditional formulation approaches.
|
|
|
